Cargando…

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD

Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in sto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buderus, Stephan, Boone, James H., Lentze, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458270/ https://www.ncbi.nlm.nih.gov/pubmed/26089872 http://dx.doi.org/10.1155/2015/578527

Ejemplares similares

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®
por: de Laffolie, Jan, et al.
Publicado: (2017)

Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children
por: Prata, Mara de Moura Gondim, et al.
Publicado: (2016)

Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease
por: Sorrentino, Dario, et al.
Publicado: (2021)

Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and Calprotectin
por: Langhorst, Jost, et al.
Publicado: (2020)

Assessment of Growth Disturbance in Japanese Children with IBD
por: Shono, Tetsuo, et al.
Publicado: (2010)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy
por: Moastafa, Tarek M., et al.
Publicado: (2014)

Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD
por: Klepsch, Victoria, et al.
Publicado: (2019)

Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results
por: Kyle, Barry D, et al.
Publicado: (2020)

Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD
por: el Manouni el Hassani, Sofia, et al.
Publicado: (2019)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Lactoferrin Levels in the Gastric Tissue of Helicobacter pylori-Positive and -Negative Patients and Its Effect on Anemia
por: Doğan, Yaşar, et al.
Publicado: (2012)

The Role of Lactoferrin in Intestinal Health
por: Conesa, Celia, et al.
Publicado: (2023)

Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease
Publicado: (2021)

Vaginal Lactoferrin Modulates PGE(2), MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations
por: Trentini, Alessandro, et al.
Publicado: (2016)

Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis
por: Saiz-Gonzalo, Gonzalo, et al.
Publicado: (2021)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Elmaghrawy, Khalid, et al.
Publicado: (2021)

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
por: Garza-González, Elvira, et al.
Publicado: (2019)

Lactoferrin in Aseptic and Septic Inflammation
por: Lepanto, Maria Stefania, et al.
Publicado: (2019)

Most Reliable Time in Predicting Residual Kyphosis and Stability: Pediatric Spinal Tuberculosis
por: Moon, Myung-Sang, et al.
Publicado: (2018)

Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
por: Fu, Yu, et al.
Publicado: (2017)

Lactoferrin Decreases the Intestinal Inflammation Triggered by a Soybean Meal-Based Diet in Zebrafish
por: Ulloa, Pilar E., et al.
Publicado: (2016)

Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
por: Campione, Elena, et al.
Publicado: (2020)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
por: Huang, Vivian W., et al.
Publicado: (2015)

Molecular Genetic Architecture of Monogenic Pediatric IBD Differs from Complex Pediatric and Adult IBD
por: Jezernik, Gregor, et al.
Publicado: (2020)

THE INVOLVEMENT OF LACTOFERRIN IN THE HYPOSIDEREMIA OF ACUTE INFLAMMATION
por: van Snick, Jacques L., et al.
Publicado: (1974)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

The Abnormal Measures of Iron Homeostasis in Pediatric Obesity Are Associated with the Inflammation of Obesity
por: Richardson, Matthew W., et al.
Publicado: (2009)

The Impact of Lactoferrin on the Growth of Intestinal Inhabitant Bacteria
por: Vega-Bautista, Alan, et al.
Publicado: (2019)

Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD
por: Lissner, Donata, et al.
Publicado: (2015)

Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut
por: Garcia-Carbonell, Ricard, et al.
Publicado: (2019)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
por: Kim, Su Yeong, et al.
Publicado: (2019)

The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation
por: Majka, Grzegorz, et al.
Publicado: (2016)

Fecal Biomarkers of Intestinal Health and Disease in Children
por: Pang, Tamara, et al.
Publicado: (2014)

Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation
por: Chassaing, Benoit, et al.
Publicado: (2012)

Lactoferrin in a Context of Inflammation-Induced Pathology
por: Kruzel, Marian L., et al.
Publicado: (2017)

Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
por: Polovina, Marija M., et al.
Publicado: (2015)

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
por: Szymanska, Edyta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0jb1n3s78drt0203k2dg4541at